237 related articles for article (PubMed ID: 16518340)
1. Leptin and inflammation-associated cachexia in chronic kidney disease.
Mak RH; Cheung W; Cone RD; Marks DL
Kidney Int; 2006 Mar; 69(5):794-7. PubMed ID: 16518340
[TBL] [Abstract][Full Text] [Related]
2. Role of leptin and melanocortin signaling in uremia-associated cachexia.
Cheung W; Yu PX; Little BM; Cone RD; Marks DL; Mak RH
J Clin Invest; 2005 Jun; 115(6):1659-65. PubMed ID: 15931394
[TBL] [Abstract][Full Text] [Related]
3. Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease.
Mak RH; Cheung W; Cone RD; Marks DL
Pediatr Nephrol; 2005 Mar; 20(3):427-31. PubMed ID: 15662537
[TBL] [Abstract][Full Text] [Related]
4. Exploiting the therapeutic potential of leptin signaling in cachexia.
Mak RH; Cheung WW; Gertler A
Curr Opin Support Palliat Care; 2014 Dec; 8(4):352-7. PubMed ID: 25259544
[TBL] [Abstract][Full Text] [Related]
5. A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.
Cheung WW; Ding W; Gunta SS; Gu Y; Tabakman R; Klapper LN; Gertler A; Mak RH
J Am Soc Nephrol; 2014 Jan; 25(1):119-28. PubMed ID: 24115476
[TBL] [Abstract][Full Text] [Related]
6. Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes.
Meek TH; Matsen ME; Damian V; Cubelo A; Chua SC; Morton GJ
Endocrinology; 2014 Nov; 155(11):4157-67. PubMed ID: 25137027
[TBL] [Abstract][Full Text] [Related]
7. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin.
Rahmouni K; Haynes WG; Morgan DA; Mark AL
J Neurosci; 2003 Jul; 23(14):5998-6004. PubMed ID: 12853417
[TBL] [Abstract][Full Text] [Related]
8. Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice.
Cheung WW; Kuo HJ; Markison S; Chen C; Foster AC; Marks DL; Mak RH
J Am Soc Nephrol; 2007 Sep; 18(9):2517-24. PubMed ID: 17687077
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and cachexia in chronic kidney disease.
Cheung WW; Paik KH; Mak RH
Pediatr Nephrol; 2010 Apr; 25(4):711-24. PubMed ID: 20111974
[TBL] [Abstract][Full Text] [Related]
10. Energy homeostasis and cachexia in chronic kidney disease.
Mak RH; Cheung W
Pediatr Nephrol; 2006 Dec; 21(12):1807-14. PubMed ID: 16897005
[TBL] [Abstract][Full Text] [Related]
11. Leptin and melanocortin signaling in the hypothalamus.
Bjørbaek C; Hollenberg AN
Vitam Horm; 2002; 65():281-311. PubMed ID: 12481551
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia.
Mak RH; Cheung W; Cone RD; Marks DL
Nat Clin Pract Nephrol; 2006 Sep; 2(9):527-34. PubMed ID: 16941045
[TBL] [Abstract][Full Text] [Related]
13. Modulation of melanocortin signaling ameliorates uremic cachexia.
Cheung WW; Rosengren S; Boyle DL; Mak RH
Kidney Int; 2008 Jul; 74(2):180-6. PubMed ID: 18432186
[TBL] [Abstract][Full Text] [Related]
14. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
Ebihara K; Ogawa Y; Katsuura G; Numata Y; Masuzaki H; Satoh N; Tamaki M; Yoshioka T; Hayase M; Matsuoka N; Aizawa-Abe M; Yoshimasa Y; Nakao K
Diabetes; 1999 Oct; 48(10):2028-33. PubMed ID: 10512369
[TBL] [Abstract][Full Text] [Related]
15. Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.
Cheung WW; Mak RH
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1315-24. PubMed ID: 22914778
[TBL] [Abstract][Full Text] [Related]
16. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction.
Hohmann JG; Teal TH; Clifton DK; Davis J; Hruby VJ; Han G; Steiner RA
Am J Physiol Regul Integr Comp Physiol; 2000 Jan; 278(1):R50-9. PubMed ID: 10644621
[TBL] [Abstract][Full Text] [Related]
17. The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure.
Shimizu H; Inoue K; Mori M
J Endocrinol; 2007 Apr; 193(1):1-9. PubMed ID: 17400797
[TBL] [Abstract][Full Text] [Related]
18. Leptin signaling, adiposity, and energy balance.
Jéquier E
Ann N Y Acad Sci; 2002 Jun; 967():379-88. PubMed ID: 12079865
[TBL] [Abstract][Full Text] [Related]
19. Preparation of Potent Leptin Receptor Antagonists and Their Therapeutic Use in Mouse Models of Uremic Cachexia and Kidney Fibrosis.
Mak RH; Cheung WW; Solomon G; Gertler A
Curr Pharm Des; 2018; 24(9):1012-1018. PubMed ID: 29366406
[TBL] [Abstract][Full Text] [Related]
20. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.
Joppa MA; Gogas KR; Foster AC; Markison S
Peptides; 2007 Mar; 28(3):636-42. PubMed ID: 17204351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
